Founded by experts in the data analytics industry, Veritas Data Research uses cutting-edge technology and efficient workflow design to collect, curate, and distribute foundational reference datasets.

Datavant provides solutions to help institutions protect, match, and share health data. We have built the world's largest health data ecosystem, including leading academic medical centers, the top analytics companies in healthcare, and the nation's largest data aggregators – as well as individual life sciences companies, health systems and insurers.

UPK is a pioneering provider of software solutions that support real-world Big Data analysis of healthcare data in a secure and HIPAA-compliant manner. UPK software and services enable healthcare organizations to quickly and easily apply a risk-based de-identification methodology to ensure individual privacy and regulatory compliance. UPK’s software is compliant with regulations and globally accepted standards and guidelines.

TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. • Designed and launched TGaS Vendor Insights (the Angie’s List / Yelp / TripAdvisor of pharma vendors), which was honored with an Innovation Award from PM360 in December, 2016.• Managed the development and build of the user interface and database of the online tool, including the workflow screens of the administrative interfaces.• Created all sales and marketing materials to support the sale of charter memberships to early adopters, and subsequent materials to support the official launch of the product.• Coordinated data collection from 68 biopharma companies using a variety of digital and paper-based methodologies to build a database of over 1,500 pharma-specific vendor profiles and performance ratings

MedPanel specializes in providing primary research involving medical and healthcare decision makers for the life science industry and life science industry investors. • Recruited and managed team of market research analysts in the successful completion of projects for clients on topics including: market sizing, client segmentation, barriers to adoption, message testing, and pricing potential.• Managed the build of a new online engagement and payment platform for market research participants, designed to expand MedPanel’s proprietary network of healthcare stakeholders.• Designed and built Plexuus, a novel online marketplace for physicians to participate in non-clinical consulting and market research engagements while assisting their employers (hospitals and health systems) in compliance with new Sunshine Act reporting regulations.• Successfully assisted board in selling MedPanel core business to small group of investors, and spun out Plexuus as a new business.

• Key member of management team pitches to acquirers, including drafting the offering memorandum, explaining DRG’s go-to-market strategy and growth opportunities, and demonstrating major products and innovations. Resulted in sale of company for $635 million to Piramal Healthcare.• Led the rationalization of all Biopharma products to eliminate internal overlap from the BioTrends acquisition (Q4, 2009) and to better differentiate the value proposition of each company’s analytics and data products. • Developed novel, integrated pricing, bundling, and discount scheme to drive cross-selling and up-selling of related content across the segment.

• Responsible for the strategic growth and development of the four portfolio companies in DRG’s Biopharma segment: Decision Resources, Bio-Trends Research Group, Arlington Medical Resources, and Manhattan Research. • Drove 2011 performance for the Biopharma segment to over $70 million in revenue, with greater than 40% margin. Margin growth YOY exceeded 14%. • Leveraged best practices from each company to lead the transition from a syndicated-reports publishing mindset to the culture of a service-oriented information provider. • Developed and sponsored the build of an integrated Biopharma product delivery platform that streamlined production through common back-end workflows and tools.

• Led a team of ten analysts charged with developing new syndicated research offerings, scaling up newly launched products, and transitioning established products to the core production team. • Managed company-wide pipeline of new product ideas, overseeing the stage-gate process for making go/no-go decisions on product candidates. • Wrote and reviewed business plans for all late-stage new product candidates. Responsible for presenting product ideas to senior management to gain approval and investment.• Negotiated and managed outside partnerships for access to proprietary data upon which new products could be built.• Responsible for all new product market research with potential clients, new product templating and workflow generation, marketing collateral and pitch deck creation, and sales training.• In 2009, products created and launched from this team contributed over 10% of the company’s revenue, and included analysis of emerging markets, biosimilars, claims-data generated treatment algorithms, market access in the United States, and brand positioning and perception.

• First member of new products team, hired staff of analysts to support new product development efforts. • Prototyped, produced, and led sales and marketing of first new product launched by the company in three years.

• Project management of research and publication deadlines for all metabolic disorder products. Ownership of research strategy, content review, and client service.• Management of analyst team including hiring, training, and performance reviews.• Key contributor to in-line product development including electronic report delivery platform, streamlined presentation of market data, and DecisionBase product redesign.

• Led market research and analysis of disease markets including interviews with thought leaders, secondary research, patient segmentation models, and market forecasting. • Lead consultant on numerous primary market research cases testing physician acceptance of product profiles, assessing market potential for novel agents, segmenting disease markets, and understanding drug positioning and choice from a physician perspective.

• Co-founded the largest non-profit student-run biotechnology club in the world with 3400 members (as of 2002), 15 seminars a year, an online magazine, job postings, and resume database. • As managing director, increased membership by 223% (650 members to 2100 members), increased sponsorship revenues by 101% ($26,100 to $52,500), and coordinated first annual career fair with 35 companies and over 1000 attendees.

Graduate Thesis: “The Expression of HIV-1 Envelope Glycoproteins in Primary Cells”Laboratory of Joseph Sodroski M.D. • Managed an MIT undergraduate’s thesis research, which won MIT thesis prize• Consultant for one company and three laboratories on lentiviral vector research